sinus plus allergy PE
- Product NDC
- 41163-666
- 11-digit product format
- 411630666
- Labeler code
- 41163
- Product ID
- 41163-666_d5b59770-e4b5-4657-996d-f61ddb4b4fbf
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- chlorpheniramine maleate, phenylephrine HCl
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- United Natural Foods, Inc. dba UNFI
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2005-06-09
- Substance
- CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 4; 10 mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- sinus plus allergy PE
- Brand name suffix
- maximum strength
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHLORPHENIRAMINE MALEATE | 4 mg/1 |
| PHENYLEPHRINE HYDROCHLORIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | V1Q0O9OJ9Z, 04JA59TNSJ |
| Rxcui | 1090443 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 41163-666-08 | sinus plus allergy PEmaximum strength | 1 in 1 CARTON | TABLET | 1 | | 14 |
| 41163-666-08 | sinus plus allergy PEmaximum strength | 24 in 1 BLISTER PACK | TABLET | 24 | | 14 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CHLORPHENIRAMINE MALEATE | ACTIVE INGREDIENT | V1Q0O9OJ9Z | SINUS PLUS ALLERGY PE MAXIMUM STRENGTH (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [SUPERVALU INC.] | 1 | |
| PHENYLEPHRINE HYDROCHLORIDE | ACTIVE INGREDIENT | 04JA59TNSJ | SINUS PLUS ALLERGY PE MAXIMUM STRENGTH (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [SUPERVALU INC.] | 1 | |
| CHLORPHENIRAMINE | ACTIVE MOIETY | 3U6IO1965U | SINUS PLUS ALLERGY PE MAXIMUM STRENGTH (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [SUPERVALU INC.] | 1 | |
| PHENYLEPHRINE | ACTIVE MOIETY | 1WS297W6MV | SINUS PLUS ALLERGY PE MAXIMUM STRENGTH (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [SUPERVALU INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | SINUS PLUS ALLERGY PE MAXIMUM STRENGTH (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [SUPERVALU INC.] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | SINUS PLUS ALLERGY PE MAXIMUM STRENGTH (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [SUPERVALU INC.] | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | SINUS PLUS ALLERGY PE MAXIMUM STRENGTH (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [SUPERVALU INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | SINUS PLUS ALLERGY PE MAXIMUM STRENGTH (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [SUPERVALU INC.] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | SINUS PLUS ALLERGY PE MAXIMUM STRENGTH (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [SUPERVALU INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 41163-666 | SINUS PLUS ALLERGY PE MAXIMUM STRENGTH (CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL) TABLET [UNITED NATURAL FOODS, INC. DBA UNFI] | 13 | Current NDC, Legacy NDC, 2 package rows | 20250108_660d3c80-f249-41dd-aa93-a0b1e635ead0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 41163-666-08 | 41163066608 | 1 BLISTER PACK in 1 CARTON (41163-666-08) / 24 TABLET in 1 BLISTER PACK | 1 blister pack | 2005-06-09 | 0000-00-00 | No | No | Current |